Cellcept and Tymlos drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cellcept (mycophenolate mofetil) and Tymlos (abaloparatide). Common drug interactions include back pain among females and hospitalisation among males.

The phase IV clinical study analyzes what interactions people have when they take Cellcept and Tymlos. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Tymlos?

Tymlos has active ingredients of abaloparatide. eHealthMe is studying from 16,516 Tymlos users. Check the latest studies of Tymlos.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 14, 2026

13 people who take Cellcept and Tymlos together, and have interactions are studied.

What are the common drug interactions of Cellcept and Tymlos, by gender? *:

female:

Back pain
Heart rate increased
Palpitations (feelings or sensations that your heart is pounding or racing)
Vertigo
Abdominal discomfort
Asthenia (weakness)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Blood alkaline phosphatase increased
Blood pressure fluctuation
Dyskinesia (abnormality or impairment of voluntary movement)

male:

Hospitalisation
Vomiting

What are the common drug interactions of Cellcept and Tymlos, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Eye pain
Headache (pain in head)
Tinnitus (a ringing in the ears)

50-59:

Abdominal discomfort
Asthenia (weakness)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Back pain
Blood pressure fluctuation
Dizziness
Fatigue (feeling of tiredness)
Headache (pain in head)
Heart rate increased
Nausea (feeling of having an urge to vomit)

60+:

Vomiting
Nausea (feeling of having an urge to vomit)
Head discomfort
Headache (pain in head)
Heart rate decreased
Nervousness
Palpitations (feelings or sensations that your heart is pounding or racing)
Urticaria (rash of round, red welts on the skin that itch intensely)
Abdominal distension
Abdominal pain upper

What are the existing conditions these people have? *

Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 8 people, 61.54%
Osteoporosis (bones weak and more likely to break): 4 people, 30.77%
Senile Osteoporosis (weak bones with ageing): 1 person, 7.69%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 7.69%
Idiopathic Thrombocytopenic Purpura (Itp) (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 1 person, 7.69%
High Blood Pressure: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and Tymlos?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously